Jan Youtie

Principal Research Associate

Member Of:
  • School of Public Policy
  • Technology Policy and Assessment Center
Email Address:
jy5@mail.gatech.edu
Office Location:
Centergy One
Related Links:

Overview

Jan L. Youtie, Ph.D., is director of policy research services and principal research associate in the Economic Development Lab, a unit of Georgia Tech’s Enterprise Innovation Institute. She is the co-founder of the program in Science, Technology, and Innovation Policy and directs the Technology, Policy Assessment Center. She is the Social and Ethical Implications Coordinator for the Southeastern Nanotechnology Infrastructure Corridor. Dr. Youtie’s research focuses on technology-based economic development, advanced manufacturing, emerging technology assessment, bibliometric and patent analysis, and innovation and knowledge measurement and evaluation. She has been an investigator in studies sponsored by the U.S. Department of Commerce, National Science Foundation, European Commission, U.N. Development Program, Inter-American Development Bank, Aspen Institute, Southern Technology Council, and Georgia Research Alliance among others. Her research received the Lang Rosen Gold Award for best article by the Journal of Technology Transfer, and it also has appeared in Research Policy, Economic Development Quarterly, Journal of Technology Transfer, Technovation, Research Evaluation, Evaluation and Program Planning, Nature Nanotechnology, and many other journals. She has been recognized as one of the top authors in technology and innovation management research by the International Association of Management of Technology. She holds a doctorate in political science from Emory University.

Education:
  • PhD - Political Science Emory University 1981
  • MA - Political Science Emory University 1979
  • BS - Political Science Emory University 1977

Interests

Research Fields:
  • Economic Development and Smart Cities
  • Program Evaluation, Public Management and Administration
  • Science, Technology, and Innovation Policy
Issues:
  • Emerging Technologies - Innovation
  • Evaluation
  • Small and Midsize Enterprises

Courses

  • PUBP-3130: Research Methods
  • PUBP-4010: Policy Task Force I
  • PUBP-4020: Policy Task Force II
  • PUBP-4260: Econ Dev Policy & PLan
  • PUBP-4843: Special Topics
  • PUBP-6602: Econ Dev Analy& Practice
  • PUBP-6741: Geography of Innovation

Recent Publications

Journal Articles

  • Exploring new approaches to understanding innovation ecosystems
    In: Technology Analysis & Strategic Management, [Peer Reviewed]
    Date: September 2021

    Jan Youtie, Robert Ward, Philip Shapira, R. Sandra Schillo & E. Louise Earl (2021) Exploring new approaches to understanding innovation ecosystems, Technology Analysis & Strategic Management, DOI: 10.1080/09537325.2021.1972965

    View All Details about Exploring new approaches to understanding innovation ecosystems

  • Corporate engagement with nanotechnology through research publications
    In: Journal of Nanoparticle Research [Peer Reviewed]
    Date: March 2021

    Assessing corporate engagement with an emerging technology is essential for understanding the development of research and innovation systems. Corporate publishing is used as a system-level knowledge transfer indicator, but prior literature suggests that publishing can run counter to private sector needs for management of dissemination to ensure appropriability of research benefits. We examine the extent of corporate authorship and collaboration in nanotechnology publications from 2000 to 2019. The analysis identified 53,200 corporate  nanotechnology publications. Despite the potential for limits on collaboration with corporate authors, this paper finds that eight out of 10 nanotechnology corporate publications involved authors from multiple organizations and nearly one-third from multiple countries and that these percentages were higher in recent years. The USA is the leading nation in corporate nanotechnology publishing, followed by Japan and Germany, with China ranking fourth, albeit with the greatest publication growth rate. US corporate publishing is more highly cited and less cross-nationally collaborative. Asian countries also have fewer collaborative authorship ties outside of their home countries. European countries had more corporate collaborations with authors affiliated with organizations outside of their home countries. The paper concludes that distinguishing corporate publications,
    while difficult due to challenges in identifying small and medium-sized corporations and grouping variations in corporate names, can be beneficial to examining national systems of research and development.

    View All Details about Corporate engagement with nanotechnology through research publications

Chapters

  • Scientists’ and the Public’s Views of Synthetic Biology
    In: Synthetic Biology 2020: Frontiers in Risk Analysis and Governance
    Date: 2020

    This chapter examines similarities and differences between scientists’ and nonscientists’ views of synthetic biology and the factors that shape them, as well as limitations of available research and the need for more focus on the views of both groups. We combine data from a survey of researchers in synthetic biology and a nationally representative survey of US adults on synthetic biology to compare the characteristics of respondents in each group and how those general characteristics could shape each group’s views. Our analyses found substantial religious and ideological differences between experts and members of the public in the US. We also found that levels of religious guidance and political ideology relate to different perceptions of synthetic biology and in different ways depending on one’s experience as either a researcher in the field or as a member of the public. We call for more, and more detailed, social science research to facilitate effective public engagement that creates space for the variety of views and concerns that will shape synthetic biology and its governance.

    View All Details about Scientists’ and the Public’s Views of Synthetic Biology